Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ischemic Heart Disease

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 218 articles:
HTML format



Single Articles


    June 2025
  1. CAMPO G, Pavasini R
    Response by Campo and Pavasini to Letter Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1049-e1050.
    PubMed    


  2. PAN D, Wu W, Chen M
    Letter by Pan et al Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1047-e1048.
    PubMed    


  3. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jun 9. doi: 10.1161/CIR.0000000000001341.
    PubMed     Abstract available


  4. LEE S, Hwang SH, Park S, Son Y, et al
    Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.073086.
    PubMed     Abstract available


  5. OBEL LM, Skovbo JS, Diederichsen ACP, Thomassen M, et al
    Aortic Aneurysm Risk and Somatic JAK2(V617F)Variation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.074002.
    PubMed     Abstract available


  6. CHU L, Wang R, Gross CP, Wei J, et al
    Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States.
    Circulation. 2025 Jun 3. doi: 10.1161/CIRCULATIONAHA.124.073614.
    PubMed     Abstract available


  7. GREGSON J, Taylor D, Owen R, Collier T, et al
    Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance.
    Circulation. 2025;151:1606-1619.
    PubMed     Abstract available


    May 2025
  8. SCHNEEWEISS S, Kruger N
    Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
    Circulation. 2025;151:1495-1497.
    PubMed    


  9. BERRY C, McCartney P
    Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
    Circulation. 2025;151:e1002-e1003.
    PubMed    


  10. BULLUCK H, Hausenloy DJ
    Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
    Circulation. 2025;151:e1004-e1005.
    PubMed    


  11. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
    Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
    Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
    PubMed     Abstract available


  12. ZHANG Z, Yang X, Zhang Z
    Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e986-e987.
    PubMed    


  13. REITAN C, Andell P, Hofmann R, Jernberg T, et al
    Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e988-e989.
    PubMed    


  14. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025;151:e1000.
    PubMed    


  15. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
    The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
    Circulation. 2025;151:1430-1432.
    PubMed    


    April 2025
  16. CLARKE R, Wright N, Lin K, Yu C, et al
    Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
    Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
    PubMed     Abstract available


  17. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2025;151:e965-e966.
    PubMed    


  18. DONG J, Yang X, Zhang W
    Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e962-e963.
    PubMed    


  19. BONNESEN K, Heide-Jorgensen U, Schmidt M
    Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e964.
    PubMed    


  20. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
    Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
    PubMed     Abstract available


  21. LV H, Wang C, Liu Z, Quan M, et al
    Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
    PubMed     Abstract available


  22. BERRY JD, Zabad N, Kyrouac D, Leonard D, et al
    High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study.
    Circulation. 2025 Apr 21. doi: 10.1161/CIRCULATIONAHA.124.070335.
    PubMed     Abstract available


  23. GRAVEN LJ, Kitko L, Abshire Saylor M, Allen L, et al
    Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 17. doi: 10.1161/CIR.0000000000001323.
    PubMed     Abstract available


  24. STAMATAKIS E, Biswas RK, Koemel NA, Sabag A, et al
    Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality.
    Circulation. 2025;151:1063-1075.
    PubMed     Abstract available


  25. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316.
    PubMed     Abstract available


  26. CHEN Q, Zheng A, Xu X, Shi Z, et al
    Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2.
    Circulation. 2025;151:1024-1046.
    PubMed     Abstract available


  27. LAM NT, Nguyen NUN, Elhelaly WM, Hsu CC, et al
    Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility.
    Circulation. 2025;151:1009-1023.
    PubMed     Abstract available


  28. BENOWITZ NL
    Predicting Cardiovascular Risk With Use of Various Tobacco Products.
    Circulation. 2025;151:1006-1008.
    PubMed    


  29. STEG PG, Szarek M, Jukema JW, Bhatt DL, et al
    Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of O
    Circulation. 2025;151:1047-1050.
    PubMed    


  30. POWELL-WILEY TM, Brewer LC, Burke LE, Hernandez R, et al
    Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314.
    PubMed     Abstract available


  31. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
    Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
    PubMed     Abstract available


  32. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e865.
    PubMed    


  33. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025;151:e864.
    PubMed    


  34. YU M, Cheng X
    Response by Yu and Cheng to Letter Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e769-e770.
    PubMed    


  35. KAKIZAKI R, Raber L
    Letter by Kakizaki and Raber Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e767-e768.
    PubMed    


    March 2025
  36. MARX N, Deanfield JE, Mann JFE, Arechavaleta R, et al
    Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
    Circulation. 2025 Mar 29. doi: 10.1161/CIRCULATIONAHA.125.074545.
    PubMed     Abstract available


  37. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
    Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
    Circulation. 2025 Mar 28. doi: 10.1161/CIRCULATIONAHA.125.074517.
    PubMed    


  38. RYAN TD, Bates JE, Kinahan KE, Leger KJ, et al
    Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 19. doi: 10.1161/CIR.0000000000001308.
    PubMed     Abstract available


  39. NDUMELE CE, Ferdinand KC, Khan SS
    The Role of Race in Cardiovascular Disease Risk Prediction.
    Circulation. 2025;151:741-743.
    PubMed    


  40. HULL LE, Aday AW, Bui QM, Luzum JA, et al
    Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 13. doi: 10.1161/CIR.0000000000001304.
    PubMed     Abstract available


  41. KURAMITSU S, Kawase Y, Shinozaki T, Domei T, et al
    Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE Registry.
    Circulation. 2025;151:672-685.
    PubMed     Abstract available


  42. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Correction to: Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2025;151:e709.
    PubMed    


  43. CLAUDEL SE, Verma A
    Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.
    Circulation. 2025;151:716-732.
    PubMed     Abstract available


  44. ARUNOTHAYARAJ S, Egred M, Banning AP, Brunel P, et al
    Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.
    Circulation. 2025;151:612-622.
    PubMed     Abstract available


  45. KOU S, Lu Z, Deng D, Ye M, et al
    Activation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury.
    Circulation. 2025;151:623-639.
    PubMed     Abstract available


    February 2025
  46. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309.
    PubMed     Abstract available



  47. Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
    Circulation. 2025;151:e681.
    PubMed    



  48. Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018.
    Circulation. 2025;151:e680.
    PubMed    


  49. STARK AW, Matthey-de-l'Endroit RL, Ferroni A, Kakizaki R, et al
    Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study.
    Circulation. 2025;151:578-580.
    PubMed    


  50. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Feb 20. doi: 10.1161/CIR.0000000000001297.
    PubMed     Abstract available


  51. ARMILLOTTA M, Bergamaschi L, Paolisso P, Belmonte M, et al
    Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2025 Feb 19. doi: 10.1161/CIRCULATIONAHA.124.070729.
    PubMed     Abstract available


  52. NELLIPUDI JA, Kelly B, Hardikar A
    Addressing Cardiovascular Health Inequities in Indigenous Women: Insights from Australia and Global Perspectives.
    Circulation. 2025;151:427-429.
    PubMed    


  53. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Traerup Andersen J, et al
    Cardiovascular Disease in Anabolic Androgenic Steroid Users.
    Circulation. 2025 Feb 13. doi: 10.1161/CIRCULATIONAHA.124.071117.
    PubMed     Abstract available


  54. KIM SM, Kim S, Kim YJ, Kim WY, et al
    Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors.
    Circulation. 2025;151:421-423.
    PubMed    


  55. BRENNAN SO, Kelly PJ, Gorey S, Synnott P, et al
    Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.
    Circulation. 2025;151:334-336.
    PubMed    


    January 2025
  56. DAI J, Zhao J, Xu X, Chen Y, et al
    Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?
    Circulation. 2025 Jan 31. doi: 10.1161/CIRCULATIONAHA.124.071855.
    PubMed     Abstract available


  57. HALL EJ, Agarwal S, Cullum CM, Sinha SS, et al
    Survivorship After Cardiogenic Shock.
    Circulation. 2025;151:257-271.
    PubMed     Abstract available


  58. SINGER Z, Wijeysundera HC, Qiu F, Fang J, et al
    Driving Restrictions and Incapacitation Vulnerability Evaluation After ST-Segment-Elevation Myocardial Infarction: DRIVE-STEMI Study.
    Circulation. 2025;151:282-284.
    PubMed    



  59. Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2025;151:e30.
    PubMed    


  60. MAURICIO R, Sharma G, Lewey J, Tompkins R, et al
    Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292.
    PubMed     Abstract available


  61. CHEN JZ, Liang Y, Liang B
    Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
    Circulation. 2025;151:e22.
    PubMed    


  62. SUN M, He S, Hu J, Zhang Y, et al
    Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
    Circulation. 2025;151:e23.
    PubMed    


  63. SIDIQI AW, Dad Zada D, Exeer NA
    Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine.
    Circulation. 2025;151:129-131.
    PubMed    


  64. ROGNE T, Gill D
    Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study.
    Circulation. 2025;151:193-195.
    PubMed    


  65. LIU S, Deshmukh V, Meng F, Wang Y, et al
    Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.
    Circulation. 2025;151:59-75.
    PubMed     Abstract available


  66. CHEW NWS, Mehta A, Goh RSJ, Zhang A, et al
    Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
    Circulation. 2025;151:98-119.
    PubMed     Abstract available


    December 2024
  67. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
    Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
    Circulation. 2024;150:2046-2069.
    PubMed     Abstract available


  68. ZWECK E, Hassager C, Beske RP, Jensen LO, et al
    Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
    Circulation. 2024;150:1990-2003.
    PubMed     Abstract available


  69. BIRKENFELD AL, Franks PW, Mohan V
    Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
    Circulation. 2024;150:1910-1912.
    PubMed    


  70. LEWANDOWSKI AJ, Rutter MK, Collins R
    Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine.
    Circulation. 2024;150:1907-1909.
    PubMed    


  71. JONE PN, Tremoulet A, Choueiter N, Dominguez SR, et al
    Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2024;150:e481-e500.
    PubMed     Abstract available


  72. DENNISON HIMMELFARB CR, Benowitz NL, Blank MD, Bhatnagar A, et al
    Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
    Circulation. 2024 Dec 3. doi: 10.1161/CIR.0000000000001293.
    PubMed     Abstract available


  73. LINDNER JR, Morello M
    In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.
    Circulation. 2024;150:1885-1897.
    PubMed     Abstract available


  74. ARMBRUSTER S, Skali H, Wei LJ
    Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.
    Circulation. 2024;150:1823-1825.
    PubMed    


    November 2024
  75. QIN D, Modanwal R, Kitsis RN
    Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction.
    Circulation. 2024;150:1812-1814.
    PubMed    


  76. ZHANG W, Zhang J, Wang Z, Li T, et al
    Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.
    Circulation. 2024;150:1791-1811.
    PubMed     Abstract available


  77. ITZHAKI BEN ZADOK O, Simitsis P, Jacobson C, Nadeem O, et al
    Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
    Circulation. 2024;150:1815-1817.
    PubMed    


  78. JI Y, Zhang MJ, Wang W, Norby FL, et al
    Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
    Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
    PubMed     Abstract available


  79. MORROW A, Young R, Abraham GR, Hoole S, et al
    Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.
    Circulation. 2024;150:1671-1683.
    PubMed     Abstract available



  80. Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui
    Circulation. 2024;150:e466.
    PubMed    


  81. GIUGNI FR, Berry JD, Khera A, Shah AM, et al
    Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
    Circulation. 2024;150:1720-1731.
    PubMed     Abstract available


  82. HO FK, Mark PB, Lees JS, Pell JP, et al
    A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia.
    Circulation. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454.
    PubMed     Abstract available


  83. GREIF R, Bray JE, Djarv T, Drennan IR, et al
    2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288.
    PubMed     Abstract available


  84. XU X, Zhu H, Xu K
    Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e444.
    PubMed    


  85. LIANG Y, Liang B
    Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e443.
    PubMed    


  86. YAN Y, Nie S, Montalescot G
    Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
    Circulation. 2024;150:e445-e446.
    PubMed    


  87. DEZFULIAN C, McCallin TE, Bierens J, Dunne CL, et al
    2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardio
    Circulation. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274.
    PubMed     Abstract available


  88. KIM Y, Landstrom AP, Shah SH, Wu JC, et al
    Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association.
    Circulation. 2024 Nov 11. doi: 10.1161/CIR.0000000000001296.
    PubMed     Abstract available


  89. MA C, Ge J, Han Y
    Global Rounds: Advancing Cardiovascular Health in China.
    Circulation. 2024 Nov 7. doi: 10.1161/CIRCULATIONAHA.124.071544.
    PubMed    


  90. AVERBUCH T, Stelkia K, Van Spall HGC
    Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.
    Circulation. 2024;150:1490-1492.
    PubMed    


  91. BHATIA HS, Wandel S, Willeit P, Lesogor A, et al
    Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
    Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.069556.
    PubMed     Abstract available


  92. DILLON HT, Saner NJ, Ilsley T, Kliman DS, et al
    Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
    Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
    PubMed     Abstract available


    October 2024
  93. VAN DIEPEN S, Poss J, Senaratne JM, Gage A, et al
    Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management.
    Circulation. 2024;150:1459-1468.
    PubMed     Abstract available


  94. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2024;150:1478-1480.
    PubMed    


  95. GRAGNANO F, van Klaveren D, Heg D, Raber L, et al
    Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009.
    PubMed     Abstract available


  96. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, et al
    Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072281.
    PubMed     Abstract available


  97. SELLKE FW
    Bleeding After Cardiovascular Surgery: A Continuing Problem.
    Circulation. 2024;150:1324-1326.
    PubMed    


  98. RUEL M, de Lemos J, Fischbein M, Hill JA, et al
    Introduction to the 2024 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2024;150:1307.
    PubMed    


  99. HOFMANN C, Serafin A, Schwerdt OM, Fischer J, et al
    Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
    Circulation. 2024;150:1248-1267.
    PubMed     Abstract available


  100. SILBERNAGEL G, Chen YQ, Li H, Lemen D, et al
    Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality.
    Circulation. 2024 Oct 11. doi: 10.1161/CIRCULATIONAHA.124.069272.
    PubMed     Abstract available


  101. KRISTENSEN JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, et al
    Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.
    Circulation. 2024;150:1187-1198.
    PubMed     Abstract available


  102. SINNAEVE PR, Welsh RC, Arias Mendoza A, Ristic AD, et al
    Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
    Circulation. 2024;150:1151-1153.
    PubMed    


  103. RUEL M, Chikwe J
    Coronary Artery Bypass Grafting: Past and Future.
    Circulation. 2024;150:1067-1069.
    PubMed    


  104. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
    Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
    Circulation. 2024;150:1101-1120.
    PubMed     Abstract available


    September 2024
  105. ZHAO X, Williamson T, Gong Y, Epstein JA, et al
    Immunomodulatory Therapy for Ischemic Heart Disease.
    Circulation. 2024;150:1050-1058.
    PubMed     Abstract available


  106. DUAN Z, Huang Z, Lei W, Zhang K, et al
    Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics.
    Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.123.065935.
    PubMed     Abstract available


  107. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
    Response by Giacoppo et al to Letter Regarding Article "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
    Circulation. 2024;150:e271-e272.
    PubMed    


  108. ZHANG Z
    Letter by Zhang Regarding Article, "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
    Circulation. 2024;150:e269-e270.
    PubMed    


  109. KOTWAL SS, Perkovic V
    Kidney Disease as a Cardiovascular Disease Priority.
    Circulation. 2024;150:975-977.
    PubMed    


  110. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
    2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001285.
    PubMed     Abstract available


  111. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001289.
    PubMed     Abstract available


  112. LEE DH
    Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants.
    Circulation. 2024;150:908-910.
    PubMed    


  113. SHAH NS, Kandula NR, Commodore-Mensah Y, Morey BN, et al
    Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Sep 16. doi: 10.1161/CIR.0000000000001278.
    PubMed     Abstract available


  114. BUTALA NM, Bucholz EM
    Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained.
    Circulation. 2024;150:836-837.
    PubMed    


  115. BEI Y, Zhu Y, Zhou J, Ai S, et al
    Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.
    Circulation. 2024;150:848-866.
    PubMed     Abstract available


  116. DIWAN A
    The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
    Circulation. 2024;150:787-790.
    PubMed    


  117. WYANT GA, Jiang Q, Singh M, Qayyum S, et al
    Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
    Circulation. 2024;150:770-786.
    PubMed     Abstract available


  118. VOLPP KG
    Using Behavioral Science to Improve Cardiovascular Health.
    Circulation. 2024;150:743-745.
    PubMed    


  119. SIMON T, Herbert BM, Brooks MM, Goodman SG, et al
    Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
    Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.069917.
    PubMed    


  120. CAMPO G, Bohm F, Engstrom T, Smits PC, et al
    Complete vs. Culprit-Only Revascularization in Older Patients with ST-segment Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
    Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071493.
    PubMed     Abstract available


    August 2024
  121. BODEN WE, De Caterina R, Kaski JC, Bairey Merz CN, et al
    Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.123.065656.
    PubMed     Abstract available


  122. NEUEN BL, Fletcher RA, Heath L, Perkovic A, et al
    Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
    PubMed     Abstract available


  123. DEFILIPPIS AP, Abbott JD, Herbert BM, Bertolet MH, et al
    Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
    Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.071208.
    PubMed     Abstract available


  124. BONNESEN K, Heide-Jorgensen U, Christensen DH, Lash TL, et al
    Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.068613.
    PubMed     Abstract available


  125. DELWARDE C, Aikawa M
    Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
    Circulation. 2024;150:706-709.
    PubMed    


  126. LI J, Sun S, Zhu D, Mei X, et al
    Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.
    Circulation. 2024;150:710-723.
    PubMed     Abstract available


  127. YU M, Yang Y, Dong SL, Zhao C, et al
    Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069808.
    PubMed     Abstract available


  128. KERN MJ, Seto AH
    Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results?
    Circulation. 2024;150:598-599.
    PubMed    


  129. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
    Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Circulation. 2024;150:611-621.
    PubMed     Abstract available


  130. KOVILAKATH A, Mauro AG, Valentine YA, Raucci FJ, et al
    SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
    Circulation. 2024;150:622-641.
    PubMed     Abstract available


  131. ABBATE A, Van Tassell B, Bogin V, Markley R, et al
    Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
    Circulation. 2024;150:580-582.
    PubMed    


  132. MOSLEHI JJ
    Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
    Circulation. 2024;150:513-515.
    PubMed     Abstract available


  133. MORRIS SA, Flyer JN, Yetman AT, Quezada E, et al
    Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Aug 12. doi: 10.1161/CIR.0000000000001265.
    PubMed     Abstract available


  134. LIN Y, Gil CH, Banno K, Yokoyama M, et al
    ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
    Circulation. 2024;150:451-465.
    PubMed     Abstract available


  135. BITTNER V
    Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
    Circulation. 2024;150:435-438.
    PubMed    


  136. JOYNT MADDOX KE
    Health Economics of Cardiovascular Disease in the United States.
    Circulation. 2024;150:419-421.
    PubMed    


  137. MARTINEZ-MORATA I, Schilling K, Glabonjat RA, Domingo-Relloso A, et al
    Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.124.069414.
    PubMed     Abstract available


    July 2024

  138. Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;150:e105.
    PubMed    


  139. VALGIMIGLI M, Landi A, Angiolillo DJ, Baber U, et al
    Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.
    Circulation. 2024;150:317-335.
    PubMed     Abstract available


  140. ARMSTRONG PW
    Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
    Circulation. 2024;150:258-260.
    PubMed    


  141. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
    Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
    Circulation. 2024;150:250-252.
    PubMed    


  142. WANG Y, Chen GC, Wang Z, Luo K, et al
    Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
    Circulation. 2024;150:215-229.
    PubMed     Abstract available


  143. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2024;150:243-245.
    PubMed    


  144. ADEDINSEWO D
    Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
    Circulation. 2024;150:174-176.
    PubMed    


  145. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
    Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
    Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
    PubMed     Abstract available


  146. ABBARA S, Shaw LJ
    Past, Present, and Future of CTA.
    Circulation. 2024;150:87-90.
    PubMed    


  147. FLEG JL, Huang Z, Reynolds HR, Shaw LJ, et al
    Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
    Circulation. 2024;150:165-167.
    PubMed    


  148. KUEHN BM
    Million Hearts Model Reduces Cardiovascular Events Without Increasing Care Costs.
    Circulation. 2024;150:162-164.
    PubMed    


  149. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
    Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
    Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
    PubMed     Abstract available


  150. BERRY C, Sidik NP, McEntegart MB
    Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
    Circulation. 2024;150:e5-e6.
    PubMed    


  151. NISHI T, Saito Y, Kobayashi Y
    Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
    Circulation. 2024;150:e3-e4.
    PubMed    


    June 2024
  152. KIM K, Joyce BT, Zheng Y, Nannini DR, et al
    Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.123.067992.
    PubMed     Abstract available


  153. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
    Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
    PubMed     Abstract available


  154. LIU T, Hao Y, Zhang Z, Zhou H, et al
    Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
    Circulation. 2024;149:2002-2020.
    PubMed     Abstract available


  155. JHA AK
    Letter by Jha Regarding Article, "Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial".
    Circulation. 2024;149:e1415-e1416.
    PubMed    


  156. ZHANG S, Zhang Y, Duan X, Wang B, et al
    Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism.
    Circulation. 2024;149:1982-2001.
    PubMed     Abstract available


  157. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
    Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
    Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
    PubMed     Abstract available


  158. MIYAUCHI K, Iwata H, Nishizaki Y, Inoue T, et al
    Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
    Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520.
    PubMed     Abstract available



  159. Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1411.
    PubMed    


  160. HUNDLEY WG
    Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis.
    Circulation. 2024;149:1859-1861.
    PubMed    


  161. ANDREOTTI F, Burzotta F, Maggioni AP
    Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".
    Circulation. 2024;149:e1312.
    PubMed    


  162. GURAGAIN B, Wei Y, Zhang H, Kahn-Krell A, et al
    Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium.
    Circulation. 2024;149:1855-1857.
    PubMed    


  163. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
    Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
    PubMed     Abstract available


  164. MORAN AE, Goldman L
    Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown.
    Circulation. 2024 Jun 4. doi: 10.1161/CIRCULATIONAHA.124.070265.
    PubMed    


  165. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
    PubMed     Abstract available


    May 2024
  166. MEHTA LS, Churchwell K, Coleman D, Davidson J, et al
    Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association.
    Circulation. 2024 May 30. doi: 10.1161/CIR.0000000000001259.
    PubMed     Abstract available


  167. NAKAMORI S, Amyar A, Fahmy AS, Ngo LH, et al
    Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
    Circulation. 2024 May 29. doi: 10.1161/CIRCULATIONAHA.123.067107.
    PubMed     Abstract available


  168. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
    Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
    Circulation. 2024;149:1729-1748.
    PubMed     Abstract available


  169. ZHAI X, Cao S, Wang J, Qiao B, et al
    Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
    Circulation. 2024;149:1752-1769.
    PubMed     Abstract available



  170. Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1218.
    PubMed    


  171. SATTAR N, Neeland IJ, McGuire DK
    Obesity and Cardiovascular Disease: A New Dawn.
    Circulation. 2024;149:1621-1623.
    PubMed    


  172. ZHU Q, Scherer PE
    Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
    Circulation. 2024;149:1624-1626.
    PubMed    


  173. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
    Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
    PubMed     Abstract available


  174. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
    Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
    Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
    PubMed     Abstract available



  175. Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
    Circulation. 2024;149:e1189-e1190.
    PubMed    


  176. TANG WHW, Hazen SL
    Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
    Circulation. 2024;149:1543-1545.
    PubMed    


  177. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
    Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
    Circulation. 2024;149:1536-1539.
    PubMed    


    April 2024
  178. KELHAM M, Mathur A, Jones DA
    Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1133.
    PubMed    


  179. APOSTOLOS A, Karamasis GV, Tsigkas G
    Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
    Circulation. 2024;149:e1132.
    PubMed    


  180. ZAMAN S, Edwards NC, Chew DP
    Global Rounds: Cardiovascular Care in Australia and New Zealand.
    Circulation. 2024;149:1402-1404.
    PubMed    


  181. SOLOMON CG, Landrigan PJ
    Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
    Circulation. 2024;149:1400-1401.
    PubMed    


  182. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
    Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
    Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
    PubMed     Abstract available


  183. GIRI J, Kaneko T
    Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
    Circulation. 2024;149:1339-1340.
    PubMed    


  184. SHAH SH, Gerszten RE
    Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
    Circulation. 2024;149:1323-1325.
    PubMed    


  185. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
    Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
    Circulation. 2024;149:1341-1353.
    PubMed     Abstract available



  186. Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1128.
    PubMed    


  187. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
    Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
    PubMed     Abstract available


  188. PATEL SM, Kang YM, Im K, Neuen BL, et al
    Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
    PubMed     Abstract available


  189. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
    PubMed     Abstract available


  190. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
    Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
    PubMed     Abstract available


  191. CHO L, Plutzky J, Brennan D, Louie MJ, et al
    Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
    PubMed    


  192. MAEHARA A, Sugizaki Y
    Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
    Circulation. 2024;149:1087-1089.
    PubMed    


  193. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
    Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1051-e1065.
    PubMed     Abstract available


  194. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
    Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
    Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
    PubMed    


    March 2024
  195. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
    Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
    PubMed     Abstract available


  196. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
    Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
    Circulation. 2024;149:1033-1052.
    PubMed     Abstract available


  197. SERRUYS PW, Revaiah PC
    The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
    Circulation. 2024;149:973-978.
    PubMed    


  198. FENG J, Li Y, Li Y, Yin Q, et al
    Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
    Circulation. 2024;149:1004-1015.
    PubMed     Abstract available



  199. Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2024;149:e1023.
    PubMed    


  200. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
    Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
    Circulation. 2024;149:1056-1058.
    PubMed    


  201. TENG Z, Ma Y, Ma X
    Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e960-e961.
    PubMed    


  202. FRANGOGIANNIS NG
    Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e962-e963.
    PubMed    


  203. MARANO P, Mouapi K, Kim A, Mastali M, et al
    Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
    Circulation. 2024;149:970-972.
    PubMed    


  204. EVERETT BM
    The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
    Circulation. 2024;149:914-916.
    PubMed    


  205. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
    A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
    Circulation. 2024;149:902-904.
    PubMed    


  206. JUNCA G, Delgado V
    Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
    Circulation. 2024;149:822-824.
    PubMed    


  207. HEUTS S, Myers PO, Siepe M
    Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:892-893.
    PubMed    


  208. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
    Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:894-895.
    PubMed    


  209. ZIMMERMANN FM, Ding VY, Fearon WF
    Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:896.
    PubMed    


  210. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
    Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
    PubMed     Abstract available


  211. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
    Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
    Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
    PubMed     Abstract available


  212. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
    The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
    Circulation. 2024;149:732-733.
    PubMed    


  213. RAJAGOPALAN S, Brook RD
    Cardiovascular and Planetary Health: Two Sides of the Same Planet.
    Circulation. 2024;149:729-731.
    PubMed    


    February 2024
  214. CHEN Z, Zhang J, He Y
    Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:725-726.
    PubMed    


  215. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
    Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:727-728.
    PubMed    


  216. GAFFEY AE, Rollman BL, Burg MM
    Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
    Circulation. 2024;149:641-643.
    PubMed    


  217. DZAU VJ, Hodgkinson CP
    RNA Therapeutics for the Cardiovascular System.
    Circulation. 2024;149:707-716.
    PubMed     Abstract available


  218. YAN Y, Guo J, Wang X, Wang G, et al
    Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
    Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.